According to a recent analysis by an agency, the Malaysian pharmaceutical market is anticipated to increase from $2.3 billion in 2015 to $4.6 billion by 2022, reflecting a 9.5% compound annual growth rate (CAGR). Seeing this demand many manufacturers are showing interest in registering their drug products in Malaysia. Malaysia’s efforts to increase access to […]

Read More →